Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder

Cancer

Volumn 107, Issue 4, 2006, Pages 721-728

  Wright, Jonathan L ^a,c   Porter, Michael P ^a   Li, Christopher I ^b   Lange, Paul H ^a   Lin, Daniel W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Disease specific mortality; Multivariate analysis; Nonurachal; Urachal adenocarcinomas

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RARE DISEASE; RISK ASSESSMENT; URACHAL ADENOCARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SURVIVAL RATE; UNITED STATES; URACHUS; URINARY BLADDER NEOPLASMS;

EID: 33747180835     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22059     Document Type: Article

References (20)

1. Lynch CF, Cohen MB. Urinary system. Cancer. 1995;75:316-329.
2. Anderstrom C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer. 1983;52:1273-1280.
3. Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165-2172.
4. Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology. 1993;42:635-639.
5. Nakanishi K, Kawai T, Suzuki M, et al. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts. Hum Pathol. 1996;27:240-247.
6. Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003;169:1295-1298.
7. Wilson TG, Pritchett TR, Lieskovsky G, et al. Primary adenocarcinoma of bladder. Urology. 1991;38:223-226.
8. el-Mekresh MM, el-Baz MA, Abol-Enein H, et al. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol. 1998;82:206-212.
9. Kramer SA, Bredael J, Croker BP, et al. Primary non-urachal adenocarcinoma of the bladder. J Urol. 1979;121:278-281.
10. Choi H, Lamb S, Pintar K, et al. Primary signet-ring cell carcinoma of the urinary bladder. Cancer. 1984;53:1985-1990.
11. Sagalowsky A, Donohue JP. Sixteen-year survival with metastatic signet ring cell bladder carcinoma. Urology. 1980;15:501-504.
12. Smeulders N, Woodhouse CR. Neoplasia in adult exstrophy patients. BJU Int. 2001;87:623-628.
13. Dandekar NP, Dalal AV, Tongaonkar HB, et al. Adenocarcinoma of bladder. Eur J Surg Oncol. 1997;23:157-160.
14. Manunta A, Vincendeau S, Kiriakou G, et al. Non-transitional cell bladder carcinomas. BJU Int. 2005;95:497-502.
15. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol. 1984;131:1-8.
16. Mostofi FK, Thomson RV, Dean AL Jr. Mucous adenocarcinoma of the urinary bladder. Cancer. 1955;8:741-758.
17. Gill HS, Dhillon HK, Woodhouse CR. Adenocarcinoma of the urinary bladder. Br J Urol. 1989;64:138-142.
18. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2002). Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2005.
19. Burnett AL, Epstein JI, Marshall FF. Adenocarcinoma of urinary bladder: classification and management. Urology. 1991;37:315-321,
20. Santucci RA, True LD, Lange PH. Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus? Urology. 1997;49:536-540.